Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition ...

A popular obesity drug may help treat ... the medication in the weight loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along with ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug Zepbound and the obesity drug Mounjaro, reduced the ...

Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...

The makers of the weight loss drug tirzepatide ... the results of a Phase 3 study showing that the drug was effective in treating sleep apnea. Eli Lilly said that 10- and 15-milligram injections ...

Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Weight gain can bring unexpected health challenges, and for one woman, it led to the diagnosis of a serious sleep disorder.

Precision medicine and phenotyping help tailor treatments to individual patient profiles.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...